Milestone Pharmaceuticals Inc 's ability to collect accounts receivable sequentially worsen to 1.06, indicating more challenging environment then in the first quarter 2026, but still, it is a far cry from any concerns. Milestone Pharmaceuticals Inc 's Accounts Receivable average collection period in the Jun 30 2026 quarter, has increased to 344 days, from 323 days, in the Mar 31 2026 quarter.

If we take a look into Healthcare sector Milestone Pharmaceuticals Inc achieved the highest receivable turnover ratio. While receivables turnover ratio remained unchanged relative to the previous period at no. .

What is Receivable Turnover Ratio?
What is Milestone Pharmaceuticals Inc Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

MIST Receivables Turnover Ratio	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter
Y / Y Receivable Change	272.94 %	159.64 %	10.47 %	-42.2 %	-42.86 %
Y / Y Revenue Change	-	-	-	-	-
Receivable Turnover Ratio (TTM)	1.06	1.13	1.39	-	-
MIST's Total Ranking	#	#	#	#	#
Accounts Receivable average collection period days	344	322	262	-	-
Seq. Receivable Change	13.73 %	84.08 %	135.14 %	-24.24 %	-20.82 %
Seq. Revenue Change	134.87 %	-84.61 %	-	-	-

Receivable Turnover Company Ranking
Within:	No.
Major Pharmaceutical Preparations Industry	#
Healthcare Sector	#
Overall Market	#

Receivable Turnover Ratio Statistics
High	Average	Low
0	0	0

MIST Company Profile • Back to MIST Efficiency Comparisons • Compare MIST Receivables Turnover Ratio to its Competitors

Financial Statements
Milestone Pharmaceuticals Inc 's Accounts Receivable	$ 3 Millions	Visit MIST's Balance sheet
Milestone Pharmaceuticals Inc 's Sales TTM	$ 2 Millions	Visit MIST's Income Statement
Sources of MIST's Revenues		Visit MIST's Sales by Geography

Other Accounts Receivable Turnover Ratios
Major Pharmaceutical Preparations Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
MIST's Receivable Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
MIST's Growth Rates	MIST's Roa	MIST's Inventory Turnover Ratio	MIST's Dividend Comparisons
MIST's Profitability Ratios	MIST's Roi	MIST's Asset Turnover Ratio	MIST's Dividend Growth
MIST's Valuation Ratios	MIST's Roe	MIST's Financial Strength Ratios	MIST's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Jun 30 2026, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Jun 30 2026	Receivable at quarter ending Jun 30 2026
Ocular Therapeutix Inc	1.79	$ 52.054 Millions	$ 29.007 Millions
Heron Therapeutics Inc	1.76	$ 151.507 Millions	$ 85.975 Millions
Bio Green Med Solution Inc	1.75	$ 1.861 Millions	$ 1.061 Millions
EBR Systems, Inc.	1.74	$ 6.446 Millions	$ 3.714 Millions
Cytomx Therapeutics Inc	1.69	$ 18.302 Millions	$ 10.821 Millions
Biocorrx Inc	1.67	$ 0.787 Millions	$ 0.471 Millions
Prophase Labs Inc	1.59	$ 3.150 Millions	$ 1.977 Millions
Amarin Corp Plcuk	1.49	$ 186.480 Millions	$ 125.559 Millions
Skinvisible Inc	1.45	$ 0.020 Millions	$ 0.014 Millions
Lightwave Logic Inc	1.40	$ 0.250 Millions	$ 0.178 Millions
Roivant Sciences Ltd	1.39	$ 7.532 Millions	$ 5.400 Millions
Newamsterdam Pharma Company N v	1.15	$ 7.121 Millions	$ 6.167 Millions
Clene Inc	1.15	$ 0.197 Millions	$ 0.171 Millions
Instil Bio Inc	1.15	$ 8.968 Millions	$ 7.822 Millions
Scienture Holdings Inc	1.15	$ 0.821 Millions	$ 0.717 Millions
Regen Biopharma Inc	0.99	$ 0.237 Millions	$ 0.239 Millions
Prokidney Corp	0.75	$ 0.818 Millions	$ 1.088 Millions
Royalty Pharma Plc	0.50	$ 2,535.998 Millions	$ 5,116.482 Millions
Cardiff Lexington Corporation	0.46	$ 10.213 Millions	$ 22.347 Millions

Date modified: 2026-09-04T10:29:50+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.